Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy According to Revised 2010 Task Force Criteria With Inclusion of Non-Desmosomal Phospholamban Mutation Carriers - 29/09/13
, Paul A. van der Zwaag, MD, PhD f, Louise R.A. Olde Nordkamp, MD h, Hennie Bikker, PhD i, Jan D.H. Jongbloed, PhD f, Roselie Jongbloed, PhD j, Ans C.P. Wiesfeld, MD, PhD g, Moniek G.P.J. Cox, MD, PhD a, e, k, Jeroen F. van der Heijden, MD, PhD a, Douwe E. Atsma, MD, PhD k, Karin de Boer, MD, PhD l, Pieter A. Doevendans, MD, PhD a, Aryan Vink, MD, PhD b, Toon A.B. van Veen, PhD c, Dennis Dooijes, PhD d, Maarten P. van den Berg, MD, PhD g, Arthur A.M. Wilde, MD, PhD h, J. Peter van Tintelen, MD, PhD e, f, Richard N. Hauer, MD, PhD a, eAbstract |
Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is frequently associated with desmosomal mutations. However, nondesmosomal mutations may be involved. The aim of this study was to assess the contribution of a phospholamban (PLN) gene mutation to ARVD/C diagnosis according to the revised 2010 task force criteria (TFC). In 142 Dutch patients (106 men, mean age 51 ± 13 years) with proven ARVD/C (fulfillment of 2010 TFC for diagnosis), 5 known desmosomal genes (PKP2, DSP, DSC2, DSG2, and JUP) and the nondesmosomal PLN gene were screened. After genetic analysis, phenotypic characteristics of desmosomal versus PLN mutation carriers were compared. In 59 of 142 patients with ARVD/C (42%), no desmosomal mutation was found. In 19 of 142 patients (13%), the PLN founder mutation c.40_42delAGA (p.Arg14del) was identified. PLN mutation carriers more often had low-voltage electrocardiograms (p = 0.004), inverted T waves in leads V4 to V6 (p <0.001), and additional structural (p = 0.007) or functional (p = 0.017) left ventricular impairment, whereas desmosomal mutation carriers had more solitary right ventricular abnormalities. The revised TFC included 21 of 142 patients with proven ARVD/C who did not meet the 1994 TFC, including 7 PLN mutation carriers. In conclusion, there is a substantial contribution of PLN mutation to ARVD/C diagnosis by the 2010 TFC. In 32% of patients (19 of 59) with genetically unexplained proven ARVD/C, this nondesmosomal mutation was found. PLN mutation carriers have ARVD/C characteristics, including important right ventricular involvement, and additionally more often low-voltage electrocardiograms, inverted T waves in the left precordial leads, and left ventricular involvement.
Le texte complet de cet article est disponible en PDF.Plan
| This study was supported by the Grants 2007B132 and 2007B139 from the Netherlands Heart Foundation, The Hague, The Netherlands; Project 06901 from the Interuniversity Cardiology Institute of the Netherlands, Utrecht, The Netherlands; and Heart Lung Foundation Utrecht, Utrecht, The Netherlands. |
|
| See page 1205 for disclosure information. |
Vol 112 - N° 8
P. 1197-1206 - octobre 2013 Retour au numéro
Article précédent
- Prognostic Value of N-Terminal Pro-Brain Natriuretic Peptide in Outpatients With Hypertrophic Cardiomyopathy
- Rossella D'Amato, Benedetta Tomberli, Gabriele Castelli, Roberto Spoladore, Francesca Girolami, Alessandra Fornaro, Anna Caldini, Francesca Torricelli, Paolo Camici, Gian Franco Gensini, Franco Cecchi, Iacopo Olivotto
- Heterogeneity of Regional Function and Relation to Ventricular Morphology in Patients With Fontan Circulation
- Fatima I. Lunze, Karsten Lunze, Doff B. McElhinney, Steven D. Colan, Kimberlee Gauvreau, Peter E. Lange, Boris Schmitt, Felix Berger
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?